Published online before print September 14, 2007

This Article Full Text Full Text (PDF) Supplemental Material All Versions of this Article: ajpath.2007.070003v1 171/5/1431    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Virag, J. A.I. Articles by Murry, C. E. Search for Related Content PubMed PubMed Citation Articles by Virag, J. A.I. Articles by Murry, C. E.

(American Journal of Pathology. 2007;171:1431-1440.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.070003

Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair

Effects on Cell Proliferation, Scar Contraction, and Ventricular Function

Jitka A.I. Virag^*, Marsha L. Rolle^*, Julia Reece^*, Sandrine Hardouin, Eric O. Feigl and Charles E. Murry^*

From the Departments of Pathology,^* Pharmacology, and Physiology and Biophysics, University of Washington, Seattle, Washington

Fibroblast growth factor-2 (FGF2, bFGF) has been proposed to regulate wound healing and angiogenesis, but skin wound healing in FGF2-knockout (FGF2-KO) animals is only slightly delayed. To determine the role of FGF2 in myocardial infarct repair, we studied the evolution of left ventricular geometry, cell proliferation, matrix content, and cardiac function in mice lacking or overexpressing (FGF2-Tg) FGF2. Despite having no effect on initial infarct size, deletion of FGF2 resulted in reduced fibroblast proliferation and interstitial collagen deposition, decreased endothelial proliferation and vascular density, and decreased cardiomyocyte hypertrophy. Furthermore, FGF2-KO mice demonstrated a complete absence of scar contraction, resulting in increased final infarct size and marked increases in chamber size and infarct expansion. These deficits ultimately impaired left ventricular dP/dt compared with wild-type infarcted mice. Conversely, overexpression of FGF2 increased fibroblast proliferation and collagen deposition, accelerated endothelial proliferation, and enhanced cardiomyocyte hypertrophy after infarction. These changes curbed infarct expansion and preserved left ventricular function. Thus, FGF2 is an important regulator of cell proliferation, angiogenesis, collagen synthesis, myocyte hypertrophy, scar contraction, and, ultimately, left ventricular contractile function during infarct repair. FGF2 may be more important in healing of infarcts compared with skin wounds because of the mechanical stress under which infarcts heal.

This article has been cited by other articles:

				D. J. Hausenloy and D. M. Yellon Cardioprotective growth factors Cardiovasc Res, July 15, 2009; 83(2): 179 - 194. [Abstract] [Full Text] [PDF]

				O. M. Gutierrez, J. L. Januzzi, T. Isakova, K. Laliberte, K. Smith, G. Collerone, A. Sarwar, U. Hoffmann, E. Coglianese, R. Christenson, et al. Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease Circulation, May 19, 2009; 119(19): 2545 - 2552. [Abstract] [Full Text] [PDF]

				K. J. Lavine and D. M. Ornitz Shared Circuitry: Developmental Signaling Cascades Regulate Both Embryonic and Adult Coronary Vasculature Circ. Res., January 30, 2009; 104(2): 159 - 169. [Abstract] [Full Text] [PDF]

				J. Sun, S.-H. Li, S.-M. Liu, J. Wu, R. D. Weisel, Y.-F. Zhuo, T. M. Yau, R.-K. Li, and S. S. Fazel Improvement in cardiac function after bone marrow cell thearpy is associated with an increase in myocardial inflammation Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H43 - H50. [Abstract] [Full Text] [PDF]

				L. C. Zelarayan, C. Noack, B. Sekkali, J. Kmecova, C. Gehrke, A. Renger, M.-P. Zafiriou, R. van der Nagel, R. Dietz, L. J. de Windt, et al. {beta}-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation PNAS, December 16, 2008; 105(50): 19762 - 19767. [Abstract] [Full Text] [PDF]